RAD

7 Buyout Targets to Watch for in 2020

The M&A market could bounce back in 2020, and as it does, investors should keep an eye on these seven buyout targets.

7 Stocks to Buy That Have Survived the Recent Carnage

These stocks have defied the 2020 selloff. This means they may be stocks to buy for investors betting a broad market bottom is on the way.

Hidden Positives Behind the Risks in Rite Aid Stock

RAD stock has rallied nicely — and for good reason. While debt remains a key risk, there are positive developments worth highlighting.

Rite Aid Stock Is Breaking Out

RAD stock is on fire this week. And with a breakout apparently in the offing, $20 could be around the corner.

Rite Aid’s Firm Fundamentals Will Lead To A Higher Stock Price

CEO-led turnaround has made RAD stock very valuable, and cheap based on 2020 outlook, as firm fundamentals lead to a higher stock price.

Collect on Rite Aid’s Short-Term Bullishness

My regular readers know I never want to buck the tape, or go against the action in the market, which is why I am recommending a bullish call option on Rite Aid Corporation (NYSE:RAD).

Right Now the Turnaround Hopes for RAD Stock Look Overstated

RAD stock is trading as if the Rite Aid turnaround is a certainty, but it's anything but that, and that makes the stock quite risky.

5 Top Stock Trades for Friday: NVDA, ROKU, MSFT, RAD, CTL

Roku and Nvidia earnings previews, plus Centurylink, Rite Aid and Microsoft were our top stock trades for Friday.

High-Tech Disruptors Are Coming to Sink Old-School Rite Aid

RAD stock jumped higher off a strong Q4 earnings beat but without a viable recovery narrative. This is where the story ends.

Rite Aid Stock: Risk Lovers, Speculators Inquire Within

There's an old investment saying that goes something like (forgive my paraphrasing) “credit leads equity.” What that means is that a company's corporate debt can be a tell about future price action in the stock. Rite Aid recently exchanged $600 million in notes coming due in 2023 for notes maturing in 2025. While that move will help with interest expense, at least one ratings agency doesn't see a reason to upgrade the company's flimsy credit rating.

It’s Super Speculative, but RAD Stock May Actually Be a Buy

Rite Aid is still a risky play, but the technicals finally look attractive and the fundamentals are improving for RAD stock.

Rite Aid Stock Could Break $14 Resistance, Or $11 Support

Rite Aid shares have been seized with volatility, making RAD stock a toss-up play for bears and bulls alike.

After Last Month’s Epic Rally, Rite Aid Stock Could Go Lower

Outside of another short squeeze, it's tough to see RAD stock going higher long-term. Even after the rally, shares remain a sell.

Investors Will See What They Want in RAD Stock

RAD stock appears like an interesting bet considering its present market discount. However, speculators should be aware that the company’s financial health leaves much to be desired.

To Stay at $20, Rite Aid’s Got to Do More

Although Rite Aid stock has come a long way, the reality is that the fundamental picture is incredibly messy. Management must reveal more substance before investors have any confidence in the beleaguered company.

5 Not-So-Hot Stocks to Sell in 2020

While markets may roar to all-time highs in 2020, these five stocks likely will miss the party and are stocks to sell in the new year.

Rite Aid Stock Is a Bottom Fisher’s Paradise at Its Current Price

Bargains in the health-care sector like RAD stock don't come along all that often. It's time to go against the grain and pick up some shares.

Don’t Be Fooled by the Big Spike of Rite Aid Stock

RAD stock nearly tripled in the last month of 2019, but Rite Aid stock subsequently fell and looks poised for more declines.

7 Investing Resolutions to Follow in 2020

While you're going to the gym and starting a diet, why not make some investing resolutions? Try to avoid fad stocks and demand dividends.